Exploring FDA Investigational Device Exemptions

Law360, New York (December 6, 2011, 3:01 PM EST) -- On Nov. 10, 2011, the U.S. Food and Drug Administration issued two draft guidance documents: Investigational Device Exemptions for Early Feasibility Medical Device Studies, Including Certain First-in-Human Studies[1], and FDA Decisions for Investigational Device Exemption Clinical Investigations.[2]

The agency also announced a small pilot program for implementation of the early feasibility study IDE draft guidance.[3] Comments on the draft guidance documents must be submitted by Feb. 8, 2012.[4]

The FDA will begin accepting applications for the pilot program on Dec. 12, 2011.

Early Feasibility Study IDE...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.